117 related articles for article (PubMed ID: 10160093)
1. Economic evaluation of an educational campaign for early diagnosis of cutaneous melanoma.
Garattini L; Cainelli T; Tribbia G; Scopelliti D
Pharmacoeconomics; 1996 Feb; 9(2):146-55. PubMed ID: 10160093
[TBL] [Abstract][Full Text] [Related]
2. Analysis of the cost-effectiveness ratio of the health campaign for the early diagnosis of cutaneous melanoma in Trentino, Italy.
Cristofolini M; Bianchi R; Boi S; Decarli A; Hanau C; Micciolo R; Zumiani G
Cancer; 1993 Jan; 71(2):370-4. PubMed ID: 8422631
[TBL] [Abstract][Full Text] [Related]
3. Benefit Cost Analysis of Three Skin Cancer Public Education Mass-Media Campaigns Implemented in New South Wales, Australia.
Doran CM; Ling R; Byrnes J; Crane M; Shakeshaft AP; Searles A; Perez D
PLoS One; 2016; 11(1):e0147665. PubMed ID: 26824695
[TBL] [Abstract][Full Text] [Related]
4. Screening for malignant melanoma: A cost-effectiveness analysis.
Freedberg KA; Geller AC; Miller DR; Lew RA; Koh HK
J Am Acad Dermatol; 1999 Nov; 41(5 Pt 1):738-45. PubMed ID: 10534637
[TBL] [Abstract][Full Text] [Related]
5. Economic evaluation of ACE inhibitor treatment of nephropathy in patients with insulin-dependent diabetes mellitus in Italy.
Garattini L; Brunetti M; Salvioni F; Barosi M
Pharmacoeconomics; 1997 Jul; 12(1):67-75. PubMed ID: 10169388
[TBL] [Abstract][Full Text] [Related]
6. Cost-Effectiveness Analysis of a Skin Awareness Intervention for Early Detection of Skin Cancer Targeting Men Older Than 50 Years.
Gordon LG; Brynes J; Baade PD; Neale RE; Whiteman DC; Youl PH; Aitken JF; Janda M
Value Health; 2017 Apr; 20(4):593-601. PubMed ID: 28408001
[TBL] [Abstract][Full Text] [Related]
7. Health system costs of skin cancer and cost-effectiveness of skin cancer prevention and screening: a systematic review.
Gordon LG; Rowell D
Eur J Cancer Prev; 2015 Mar; 24(2):141-9. PubMed ID: 25089375
[TBL] [Abstract][Full Text] [Related]
8. [A full economic evaluation of extensive vaccination against rotavirus with RIX4414 vaccine at National and Regional level in Italy].
Vitale F; Barbieri M; Dirodi B; Vitali Rosati G; Franco E
Ann Ig; 2013; 25(1):43-56. PubMed ID: 23435779
[TBL] [Abstract][Full Text] [Related]
9. Cost effectiveness and cost utility of adjuvant interferon alpha in cutaneous melanoma: a review.
Crott R
Pharmacoeconomics; 2004; 22(9):569-80. PubMed ID: 15209526
[TBL] [Abstract][Full Text] [Related]
10. Estimated Healthcare Costs of Melanoma in Australia Over 3 Years Post-Diagnosis.
Elliott TM; Whiteman DC; Olsen CM; Gordon LG
Appl Health Econ Health Policy; 2017 Dec; 15(6):805-816. PubMed ID: 28756584
[TBL] [Abstract][Full Text] [Related]
11. Life-long screening of patients with intermediate-thickness cutaneous melanoma for asymptomatic pulmonary recurrences: a cost-effectiveness analysis.
Mooney MM; Mettlin C; Michalek AM; Petrelli NJ; Kraybill WG
Cancer; 1997 Sep; 80(6):1052-64. PubMed ID: 9305705
[TBL] [Abstract][Full Text] [Related]
12. Economic impact of healthcare resource utilisation patterns among patients diagnosed with advanced melanoma in the United Kingdom, Italy, and France: results from a retrospective, longitudinal survey (MELODY study).
Johnston K; Levy AR; Lorigan P; Maio M; Lebbe C; Middleton M; Testori A; Bédane C; Konto C; Dueymes A; Sbarigia U; van Baardewijk M
Eur J Cancer; 2012 Sep; 48(14):2175-82. PubMed ID: 22480965
[TBL] [Abstract][Full Text] [Related]
13. Economic evaluation of the US Environmental Protection Agency's SunWise program: sun protection education for young children.
Kyle JW; Hammitt JK; Lim HW; Geller AC; Hall-Jordan LH; Maibach EW; De Fabo EC; Wagner MC
Pediatrics; 2008 May; 121(5):e1074-84. PubMed ID: 18450850
[TBL] [Abstract][Full Text] [Related]
14. An economic evaluation of an abdominal aortic aneurysm screening program in Italy.
Giardina S; Pane B; Spinella G; Cafueri G; Corbo M; Brasseur P; Orengo G; Palombo D
J Vasc Surg; 2011 Oct; 54(4):938-46. PubMed ID: 21820837
[TBL] [Abstract][Full Text] [Related]
15. An estimate of the annual direct cost of treating cutaneous melanoma.
Tsao H; Rogers GS; Sober AJ
J Am Acad Dermatol; 1998 May; 38(5 Pt 1):669-80. PubMed ID: 9591809
[TBL] [Abstract][Full Text] [Related]
16. Melanoma screening: Informing public health policy with quantitative modelling.
Gilmore S
PLoS One; 2017; 12(9):e0182349. PubMed ID: 28945758
[TBL] [Abstract][Full Text] [Related]
17. Early detection of melanoma: an educational campaign in Padova, Italy.
Rossi CR; Vecchiato A; Bezze G; Mastrangelo G; Montesco MC; Mocellin S; Meneghetti G; Mazzoleni F; Peserico A; Nitti D; Lise M
Melanoma Res; 2000 Apr; 10(2):181-7. PubMed ID: 10803719
[TBL] [Abstract][Full Text] [Related]
18. Sentinel node biopsy in patients with primary cutaneous melanoma of any thickness: A cost-effectiveness analysis.
Serra-Arbeloa P; Rabines-Juárez ÁO; Álvarez-Ruiz MS; Guillén-Grima F
Surg Oncol; 2016 Sep; 25(3):205-11. PubMed ID: 27566024
[TBL] [Abstract][Full Text] [Related]
19. Estimation of Direct Melanoma-related Costs by Disease Stage and by Phase of Diagnosis and Treatment According to Clinical Guidelines.
Buja A; Sartor G; Scioni M; Vecchiato A; Bolzan M; Rebba V; Sileni VC; Palozzo AC; Montesco M; Del Fiore P; Baldo V; Rossi CR
Acta Derm Venereol; 2018 Feb; 98(2):218-224. PubMed ID: 29110018
[TBL] [Abstract][Full Text] [Related]
20. Economic evaluation of skin cancer prevention in Australia.
Shih ST; Carter R; Sinclair C; Mihalopoulos C; Vos T
Prev Med; 2009 Nov; 49(5):449-53. PubMed ID: 19747936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
